PHIO Phio Pharmaceuticals Corp. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$0,99
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$0,8452-Wochen-Tief
$4,1952-Wochen-Hoch
Marktkapitalisierung (MRQ)
$11M
P/E
-0.2
EPS
$-9.08
Ihre Abzeichen
52W-Spanne
$1–$4
Analystenbewertung
BUY
Kursziel
$14
P/E
-0.2
ROE
-57.5%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
PHIO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$0.99
Marktkapitalisierung (MRQ)
$11M
P/E
-0.2
EPS
$-9.08
ROE
-57.5%
52W-Spanne
$1–$4
PHIO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 5. Juli 2024 | 1-for-9 | Umgekehrt |
| 26. Januar 2023 | 1-for-12 | Umgekehrt |
| 15. Januar 2020 | 1-for-55 | Umgekehrt |
| 8. Januar 2018 | 1-for-10 | Umgekehrt |
| 18. April 2016 | 1-for-10 | Umgekehrt |
| 24. Juli 2013 | 1-for-30 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz·2016-12-31 → 2020-12-31
EPS$-9.082021-12-31 → 2024-12-31
Freier Cashflow$-8M2016-12-31 → 2025-12-31
Nettogewinnmarge·2016-12-31 → 2024-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | PHIO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -0.25-Jahres-Durchschnitt ≈-2.6 | ≈-2.6 | · | · | |
| K/B (MRQ) | 0.95-Jahres-Durchschnitt ≈2.2 | ≈2.2 | 1.4 | Unterbewertet | |
| Kurs / FCF (TTM) | -0.95-Jahres-Durchschnitt ≈-2.0 | ≈-2.0 | · | · | |
| Kurs / Cashflow (TTM) | -0.95-Jahres-Durchschnitt ≈-2.0 | ≈-2.0 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 0.65-Jahres-Durchschnitt ≈15.1 | ≈15.1 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | PHIO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -63.9%5-Jahres-Durchschnitt ≈-79.2% | ≈-79.2% | -94.8% | Spitzenklasse | |
| ROE | -57.5%5-Jahres-Durchschnitt ≈-111.1% | ≈-111.1% | -165.1% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.17%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.36 | $-0.37 | 2.0% |
| 31. März 2026 | Mai 13, 2026 | $-0.34 | $-0.24 | -41.8% |
| 31. Dezember 2025 | $-0.25 | $-0.35 | 27.0% | |
| 30. September 2025 | $-0.44 | $-0.46 | 4.1% | |
| 30. Juni 2025 | $-0.45 | $-0.37 | -22.5% | |
| 31. Dezember 2024 | $-0.85 | $-1.25 | 32.2% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $0 | $21.0K | $138.0K | $15.0K | $19.0K | $34.0K | · | |
| R&D Expense | $5M | $4M | $6M | $7M | $9M | $4M | $4M | $4M | $5M | $5M | $7M | $6M | |
| SG&A Expense | $5M | $4M | $4M | $4M | $5M | $5M | $5M | $3M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $9M | $7M | $11M | $11M | $14M | $9M | $9M | $8M | $14M | $9M | $10M | $9M | |
| Operating Income | $-9M | $-7M | $-11M | $-11M | $-14M | $-9M | $-9M | $-7M | $-14M | $-9M | $-10M | $-9M | |
| Other Non-op | $2.0K | $6.0K | $-2.0K | $-18.0K | $224.0K | $-1.0K | $79.0K | $4.0K | $-11.0K | $6.0K | $-2.0K | $9.0K | |
| Pretax Income | · | · | · | $-11M | $-13M | $-9M | $-9M | $-7M | $-14M | $-9M | $-10M | $-9M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-2M | $0 | $0 | $0 | |
| Net Income | $-9M | $-7M | $-11M | $-11M | $-13M | $-9M | $-9M | $-7M | $-12M | $-9M | $-10M | $-9M | |
| EPS (Basic) | $-1.45 | $-9.08 | $-46.76 | $-10.10 | $-12.43 | · | · | · | · | · | · | · | |
| EPS (Diluted) | · | $-9.08 | $-46.76 | $-10.10 | $-12.43 | · | · | · | · | · | · | · | |
| Shares (Basic) | 5,984,017 | 787,466 | 231,508 | 1,136,566 | 1,069,234 | · | · | · | · | · | · | · | |
| Shares (Diluted) | · | 787,466 | 231,508 | 1,136,566 | 1,069,234 | · | · | · | · | · | · | · | |
| EBITDA | $-9M | $-7M | $-11M | $-11M | · | $-9M | $-9M | $-7M | $-14M | $-9M | $-10M | $-9M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $5M | $8M | $12M | $24M | $14M | $7M | $15M | $4M | $13M | $5M | $8M | |
| Prepaid Expense | $445.0K | $354.0K | $832.0K | $615.0K | $620.0K | $870.0K | $316.0K | $221.0K | $201.0K | $150.0K | $311.0K | $442.0K | |
| Current Assets | $21M | $6M | $9M | $12M | $25M | $15M | $7M | $15M | $4M | $13M | $11M | $9M | |
| PP&E (Net) | $11.0K | $2.0K | $6.0K | $183.0K | $133.0K | $157.0K | $210.0K | $172.0K | $248.0K | $114.0K | $163.0K | $183.0K | |
| PP&E (Gross) | $239.0K | $308.0K | $1M | $1M | $1M | · | · | · | · | · | · | · | |
| Accum. Depreciation | $228.0K | $306.0K | $1M | $1M | $1M | $1M | $1M | $981.0K | $900.0K | $831.0K | $778.0K | $702.0K | |
| Other Non-current Assets | · | $0 | $3.0K | $24.0K | $27.0K | $18.0K | $18.0K | $0 | $18.0K | $27.0K | $18.0K | $18.0K | |
| Total Assets | $21M | $6M | $9M | $13M | $25M | $16M | $8M | $15M | $4M | $13M | $11M | $9M | |
| Accounts Payable | $435.0K | $253.0K | $657.0K | $779.0K | $283.0K | $728.0K | $809.0K | $550.0K | $511.0K | $917.0K | $1M | $285.0K | |
| Accrued Liabilities | $905.0K | $762.0K | $942.0K | $1M | $3M | $1M | $964.0K | $1M | $2M | $2M | $1M | $1M | |
| Current Liabilities | · | $1M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $1M | |
| Capital Leases | · | $0 | $0 | $35.0K | $170.0K | $295.0K | $411.0K | $0 | · | · | · | · | |
| Total Liabilities | $1M | $1M | $2M | $2M | $3M | $3M | $2M | $2M | · | · | · | · | |
| Total Debt | · | · | · | · | · | $231.0K | · | · | · | · | · | · | |
| Common Stock | $1.0K | $0 | $0 | $0 | $0 | $1.0K | $1.0K | $0 | $0 | $0 | $1.0K | $2.0K | |
| Paid-in Capital | $175M | $151M | $147M | $139M | $139M | $117M | $101M | $99M | $80M | $73M | $66M | $48M | |
| Retained Earnings | $-155M | $-146M | $-139M | $-128M | $-117M | $-104M | $-95M | $-86M | $-79M | $-66M | $-57M | $-47M | |
| Stockholders' Equity | $20M | $5M | $8M | $11M | $22M | $13M | $6M | $14M | $2M | $11M | $9M | $3M | |
| Liabilities + Equity | $21M | $6M | $9M | $13M | $25M | $16M | $8M | $15M | $4M | $13M | $11M | $9M | |
| Shares Outstanding | 11,617,250 | 1,733,717 | 416,368 | 1,139,024 | 1,127,917 | 5,780,973 | 669,433 | 342,578 | 2,429,993 | 1,300,318 | 653,485 | 21,984,272 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.0K | $2.0K | $56.0K | $71.0K | $75.0K | $72.0K | $67.0K | $81.0K | $70.0K | $53.0K | $77.0K | $87.0K | |
| Stock-based Comp | $481.0K | $147.0K | $303.0K | $414.0K | $480.0K | $136.0K | $300.0K | $282.0K | $314.0K | $756.0K | $2M | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | $0 | $-2M | $-4M | $-4M | $-3M | |
| Other Non-cash | $235.0K | $-111.0K | $-282.0K | $-1M | · | $-216.0K | $-104.0K | $-523.0K | $4M | $4M | $5M | $2M | |
| Operating Cash Flow | $-8M | $-7M | $-11M | $-12M | $-12M | $-9M | $-9M | $-8M | $-10M | $-8M | $-7M | $-8M | |
| CapEx | $12.0K | $1.0K | $5.0K | $121.0K | $51.0K | $19.0K | $72.0K | $5.0K | $203.0K | $4.0K | $57.0K | $95.0K | |
| Investing Cash Flow | $-12.0K | $8.0K | $-5.0K | $-121.0K | $-51.0K | $-19.0K | $-72.0K | $-5.0K | $-103.0K | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $1M | $290.0K | · | $9M | $2M | |
| Net Stock Activity | · | · | · | · | · | · | · | $1M | · | · | $9M | $2M | |
| Financing Cash Flow | $24M | $4M | $7M | $-26.0K | $22M | $16M | $772.0K | $19M | $292.0K | · | · | · | |
| Net Change in Cash | $16M | $-3M | · | · | · | · | · | $11M | $-9M | $8M | $-3M | $-3M | |
| Free Cash Flow | $-8M | $-7M | $-11M | $-12M | · | $-9M | $-9M | $-8M | $-10M | $-8M | $-7M | $-8M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -3197.8% | · | · | · | · | -42795.2% | -5336.2% | -93746.7% | -47447.4% | · | · | |
| Net Margin | · | -3095.2% | · | · | · | · | -42419.0% | -5333.3% | -83013.3% | -47336.8% | · | · | |
| Pretax Margin | · | · | · | · | · | · | -42419.0% | -5333.3% | -93820.0% | -47336.8% | · | · | |
| EBITDA Margin | · | -3197.0% | · | · | · | · | -42476.2% | -5277.5% | -93280.0% | -47168.4% | · | · | |
| ROA | -63.9% | -94.7% | -97.6% | -60.5% | · | -74.0% | -76.3% | -75.8% | -142.3% | -73.2% | -100.5% | -73.0% | |
| ROE | -57.5% | -147.9% | -144.9% | -94.2% | · | -61.8% | -133.4% | -96.0% | -196.3% | -91.1% | -175.7% | -229.0% | |
| ROIC | · | · | · | -105.8% | · | -66.4% | -156.3% | -54.2% | -678.8% | -83.0% | -115.1% | -321.5% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 5.7 | 5.7 | 6.4 | · | 6.9 | 3.9 | 8.7 | 1.7 | 5.2 | 4.8 | 6.7 | |
| Quick Ratio | · | 5.3 | 5.2 | 6.1 | · | 6.5 | 3.7 | 8.5 | 1.6 | 5.1 | 2.3 | 6.4 | |
| Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.73 | $2.72 | $2.06 | $9.52 | · | $2.25 | $8.59 | $0.72 | $1.41 | $0.83 | $0.14 | $0.23 | |
| Revenue / Share | · | $0.29 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-9.03 | $-5.16 | $-10.67 | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.81 | $3.10 | $2.27 | $10.34 | · | $2.46 | $10.36 | $0.79 | $2.75 | $0.99 | $0.08 | $0.72 | |
| EPS (TTM) | $-6.02 | $-9.08 | $-46.76 | $-10.10 | $-12.43 | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $21.0K | $138.0K | $15.0K | $19.0K | $34.0K | $399.0K | |
| Net Income TTM | $-9M | $-7M | $-11M | $-11M | $-13M | $-9M | $-9M | $-7M | $-12M | $-9M | $-10M | $-9M | |
| Market Cap | $12M | $3M | $26M | $46M | · | $1.68B | $680M | $36.93B | $42.94B | $552.26B | $14.83T | $11.20T | |
| Enterprise Value | · | · | · | · | · | $1.67B | · | · | · | · | · | · | |
| P/E | -0.2 | -0.2 | -0.1 | -4.0 | -8.7 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | 32379.5 | 267635.7 | 2862988.0 | 29066211.3 | 436124657.3 | 28078591.4 | |
| P/B | 0.6 | 0.7 | 3.3 | 4.2 | · | 129.0 | 118.3 | 2720.1 | 23428.7 | 50875.9 | 1667968.3 | 4081369.0 | |
| P / Tangible Book | 0.6 | 0.7 | 3.3 | 4.2 | 66.7 | 129.0 | · | · | · | · | · | · | |
| P / Cash Flow | -1.5 | -0.4 | -2.4 | -3.8 | · | -190.8 | -78.7 | -4911.4 | -4513.9 | -71167.3 | -2026546.2 | -1444103.9 | |
| P / FCF | -1.5 | -0.4 | -2.4 | -3.7 | · | -190.4 | -78.0 | -4908.1 | -4419.6 | -71130.6 | -2010881.3 | -1426634.1 | |
| EV / EBITDA | · | · | · | · | · | -191.0 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -188.8 | · | · | · | · | · | · | |
| Earnings Yield | -573.3% | -504.4% | -683.6% | -25.1% | -11.5% | · | · | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $3M | $1M | $1M | $1M | $886.0K | $985.0K | $644.0K | $866.0K | $1M | $1M | $2M | $1M | $2M | $2M | $3M | |
| SG&A Expense | $1M | $1M | $1M | $1M | $1M | $986.0K | $689.0K | $946.0K | $1M | $1M | $766.0K | $968.0K | $1M | $1M | $1M | $1M | |
| Operating Expenses | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $4M | |
| Operating Income | $-4M | $-4M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-3M | $-4M | |
| Other Non-op | $0 | $3.0K | $-119.0K | $0 | $0 | $-22.0K | $-64.0K | $0 | $68.0K | $2.0K | · | $-4.0K | $-2.0K | $0 | $-1.0K | $-5.0K | |
| Net Income | $-4M | $-4M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-3M | $-4M | |
| EPS (Basic) | $-0.36 | $-0.34 | $-0.15 | $-0.44 | $-0.45 | $-0.41 | $-3.45 | $-1.54 | $-3.62 | $-0.47 | $-20.09 | $-10.25 | $-13.27 | $-3.15 | $-2.40 | $-3.14 | |
| EPS (Diluted) | · | · | · | · | $-0.45 | $-0.41 | · | $-1.54 | $-3.62 | $-0.47 | $-20.09 | $-10.25 | $-13.27 | $-3.15 | $-2.40 | $-3.14 | |
| Shares (Basic) | 11,617,250 | 11,617,250 | · | 5,468,584 | 4,794,857 | 4,307,264 | · | 990,033 | 510,188 | 4,580,072 | · | 271,129 | 192,054 | 1,142,213 | · | 1,138,571 | |
| Shares (Diluted) | · | · | · | · | 4,794,857 | 4,307,264 | · | 990,033 | 510,188 | 4,580,072 | · | 271,129 | 192,054 | 1,142,213 | · | 1,138,571 | |
| EBITDA | $-4M | $-4M | · | $-3M | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-3M | $-3M | $-4M | · | $-4M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $17M | $21M | $11M | $11M | $13M | $5M | $5M | $5M | $6M | $8M | $8M | $11M | $9M | $12M | $14M | |
| Prepaid Expense | $1M | $371.0K | $445.0K | $788.0K | $519.0K | $158.0K | $354.0K | $474.0K | $594.0K | $373.0K | $832.0K | $871.0K | $678.0K | $319.0K | $615.0K | $843.0K | |
| Current Assets | $14M | $17M | $21M | $11M | $11M | $13M | $6M | $6M | $5M | $7M | $9M | $9M | $12M | $9M | $12M | $15M | |
| PP&E (Net) | $9.0K | $10.0K | $11.0K | $12.0K | $7.0K | $4.0K | $2.0K | $1.0K | $1.0K | $2.0K | $6.0K | $142.0K | $157.0K | $167.0K | $183.0K | $198.0K | |
| PP&E (Gross) | · | · | $239.0K | · | · | · | $308.0K | · | · | · | $1M | · | · | · | $1M | · | |
| Accum. Depreciation | · | · | $228.0K | · | · | · | $306.0K | · | · | · | $1M | · | · | · | $1M | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | $0 | $3.0K | $3.0K | $3.0K | $3.0K | $6.0K | $6.0K | $24.0K | $24.0K | |
| Total Assets | $14M | $17M | $21M | $12M | $11M | $13M | $6M | $6M | $5M | $7M | $9M | $10M | $12M | $10M | $13M | $16M | |
| Accounts Payable | $901.0K | $260.0K | $435.0K | $516.0K | $235.0K | $427.0K | $253.0K | $184.0K | $335.0K | $320.0K | $657.0K | $173.0K | $641.0K | $902.0K | $779.0K | $543.0K | |
| Accrued Liabilities | $804.0K | $690.0K | $905.0K | $1M | $971.0K | $843.0K | $762.0K | $735.0K | $1M | $929.0K | $942.0K | $2M | $2M | $1M | $1M | $2M | |
| Current Liabilities | · | · | · | · | $1M | $1M | · | $919.0K | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $35.0K | $70.0K | |
| Total Liabilities | $2M | $950.0K | $1M | $2M | $1M | $1M | $1M | · | · | · | $2M | $2M | $2M | $2M | $2M | $2M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.0K | |
| Paid-in Capital | $176M | $176M | $175M | $163M | $160M | $160M | $151M | $150M | $147M | $147M | $147M | $145M | $144M | $139M | $139M | $139M | |
| Retained Earnings | $-163M | $-159M | $-155M | $-153M | $-150M | $-148M | $-146M | $-145M | $-143M | $-141M | $-139M | $-137M | $-135M | $-132M | $-128M | $-126M | |
| Stockholders' Equity | $13M | $16M | $20M | $10M | $10M | $12M | $5M | $5M | $4M | $6M | $8M | $7M | $10M | $7M | $11M | $14M | |
| Liabilities + Equity | $14M | $17M | $21M | $12M | $11M | $13M | $6M | $6M | $5M | $7M | $9M | $10M | $12M | $10M | $13M | $16M | |
| Shares Outstanding | 11,617,250 | 11,617,250 | 11,617,250 | 5,784,770 | 4,798,154 | 4,778,154 | 1,733,717 | 958,219 | 510,188 | 4,591,700 | 416,368 | 2,307,385 | 1,985,211 | 1,150,582 | 1,139,024 | 13,667,973 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.0K | $1.0K | $1.0K | $2.0K | $0 | $0 | $0 | $0 | $1.0K | $1.0K | $10.0K | $15.0K | $15.0K | $16.0K | $15.0K | $15.0K | |
| Stock-based Comp | $278.0K | $318.0K | $274.0K | $113.0K | $51.0K | $43.0K | $48.0K | $52.0K | $15.0K | $32.0K | $9.0K | $89.0K | $94.0K | $111.0K | $42.0K | $103.0K | |
| Other Non-cash | · | $-319.0K | · | · | · | $451.0K | · | · | · | $110.0K | · | · | · | $767.0K | · | · | |
| Operating Cash Flow | $-4M | $-4M | $-2M | $-2M | $-3M | $-1M | $-1M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-4M | |
| CapEx | $0 | $0 | $0 | $7.0K | $3.0K | $2.0K | $1.0K | $0 | $0 | $0 | $0 | $0 | $5.0K | $0 | $0 | $7.0K | |
| Investing Cash Flow | $0 | $3.0K | $0 | $-7.0K | $-3.0K | $-2.0K | $8.0K | $0 | $0 | $0 | $0 | $0 | $-5.0K | $0 | $0 | $-7.0K | |
| Financing Cash Flow | $0 | $0 | $12M | $2M | $40.0K | $9M | $1M | $3M | $0 | $-4.0K | $2M | $0 | $5M | $-38.0K | $2.0K | $-3.0K | |
| Net Change in Cash | $-4M | $-4M | $10M | $-70.0K | $-3M | $8M | $-8.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-4M | · | · | · | $-1M | · | · | · | · | · | · | · | $-3M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -32.3% | -25.9% | · | -27.5% | -26.1% | -17.4% | · | -19.8% | -21.0% | -26.0% | · | -21.9% | -15.7% | -22.6% | · | -16.4% | |
| ROE | -36.5% | -28.0% | · | -32.4% | -31.2% | -19.9% | · | -25.1% | -27.0% | -33.4% | · | -26.8% | -18.9% | -26.9% | · | -18.4% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | 9.4 | 10.6 | · | 6.4 | 3.5 | 5.5 | · | 4.0 | 5.0 | 3.9 | · | 7.0 | |
| Quick Ratio | · | · | · | · | 8.9 | 10.5 | · | 5.9 | 3.1 | 5.2 | · | 3.6 | 4.7 | 3.8 | · | 6.6 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.08 | $1.42 | · | $1.70 | $2.10 | $2.55 | · | $5.16 | $7.40 | $1.22 | · | $3.13 | $4.99 | $6.35 | · | $0.99 | |
| Cash Flow / Share | · | · | · | · | · | $-0.30 | · | · | · | $-0.44 | · | · | · | $-2.37 | · | · | |
| Cash / Share | $1.12 | $1.47 | · | $1.85 | $2.25 | $2.78 | · | $5.62 | $9.21 | $1.41 | · | $3.64 | $5.70 | $7.85 | · | $1.06 | |
| EPS (TTM) | · | · | · | · | · | · | · | $-25.72 | $-34.43 | $-44.08 | · | $-29.07 | $-21.96 | $-10.91 | · | $-19.33 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-13M | $-11M | · | $-8M | $-7M | $-7M | · | $-7M | $-9M | $-9M | · | $-12M | $-12M | $-12M | · | $-12M | |
| Market Cap | $12M | $14M | · | $14M | $11M | $6M | · | $3M | $3M | $28M | · | $31M | $51M | $58M | · | $843M | |
| P/E | · | · | · | · | · | · | · | -0.1 | -0.2 | -0.1 | · | -0.5 | -1.2 | -4.6 | · | -3.2 | |
| P/B | 0.9 | 0.9 | · | 1.5 | 1.1 | 0.5 | · | 0.7 | 0.8 | 5.0 | · | 4.3 | 5.2 | 8.0 | · | 62.3 | |
| P / Tangible Book | 0.9 | 0.9 | · | 1.5 | 1.1 | 0.5 | · | 0.7 | 0.8 | 5.0 | · | 4.3 | 5.2 | 8.0 | · | 62.3 | |
| P / Cash Flow | · | -3.5 | · | · | · | -4.9 | · | · | · | -14.0 | · | · | · | -21.5 | · | · | |
| Earnings Yield | · | · | · | · | · | · | · | -745.5% | -552.8% | -720.3% | · | -213.9% | -85.0% | -21.6% | · | -31.4% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Betriebsgewinnmarge % | · | -3197.8% | · | · | · |
| Nettoergebnis | $-9M | $-7M | $-11M | $-11M | $-13M |
| Verwässerte EPS | · | $-9.08 | $-46.76 | $-10.10 | $-12.43 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | · | 5.7 | 5.7 | 6.4 | · |
| Quick Ratio | · | 5.3 | 5.2 | 6.1 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-8M | $-7M | $-11M | $-12M | · |
Institutionelle Eigentümer (13F) 25 Einreicher · $742K gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
25
Gehaltener Wert
$742K
Neue Positionen
4
Geschlossene Positionen
4
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 4 (-11 vs. Vorquartal) | 4 (-1 vs. Vorquartal) | 6 (+1 vs. Vorquartal) | 8 (+8 vs. Vorquartal) | -21K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| JANE STREET GROUP, LLC | $120.699 | 117.755 | 16,28% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $117.437 | 114.574 | 15,84% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $96.619 | 94.262 | 13,03% | Aktien |
| VANGUARD GROUP INC | $92.009 | 87.628 | 12,41% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $51.000 | 50.000 | 6,88% | Aktien |
| Cetera Investment Advisers | $48.688 | 47.500 | 6,57% | Aktien |
| CITADEL ADVISORS LLC | $48.329 | 47.150 | 6,52% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $39.123 | 38.169 | 5,28% | Aktien |
| NORTHERN TRUST CORP | $28.462 | 27.768 | 3,84% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $22.039 | 21.501 | 2,97% | Aktien |
| XTX Topco Ltd | $18.937 | 18.475 | 2,55% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $12.300 | 12.000 | 1,66% | Aktien |
| CITIGROUP INC | $11.895 | 11.605 | 1,60% | Aktien |
| CAPTRUST FINANCIAL ADVISORS | $10.250 | 10.000 | 1,38% | Aktien |
| Tower Research Capital LLC (TRC) | $6.361 | 6.206 | 0,86% | Aktien |
| MORGAN STANLEY | $6.150 | 6.000 | 0,83% | Aktien |
| UBS Group AG | $5.522 | 5.387 | 0,74% | Aktien |
| OSAIC HOLDINGS, INC. | $2.060 | 2.000 | 0,28% | Aktien |
| Spire Wealth Management | $2.050 | 1.990 | 0,28% | Aktien |
| SBI Securities Co., Ltd. | $1.278 | 1.247 | 0,17% | Aktien |
| BARCLAYS PLC | $237 | 231 | 0,03% | Aktien |
| ASSETMARK, INC | $113 | 110 | 0,02% | Aktien |
| HRT FINANCIAL LP | $13 | 13.182 | 0,00% | Aktien |
| Activest Wealth Management | $9 | 9 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $6 | 6 | 0,00% | Aktien |
Unternehmensinsider 19 Insider · 8 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert J Bitterman | Chairman, Pres. & CEO | 28. September 2026 A | 764.871 | 7 | 0 | $44.860 |
| Gerrit Dispersyn | President & CEO | 1. März 2022 F | 212.327 | 0 | 0 | $0 |
| Lisa Cabott Carson | Chief Financial Officer | 28. September 2026 A | 189.112 | 0 | 0 | $0 |
| Robert M. Infarinato | VP, CFO | 11. September 2024 A | 11.000 | 0 | 0 | $0 |
| Caitlin Kontulis | Secretary & VP Finance & Admin | 1. März 2024 F | 10.643 | 0 | 0 | $0 |
| John A Barrett | Chief Development Officer | 22. April 2019 A | 222.991 | 0 | 0 | $0 |
| Alexey Eliseev | Chief Business Officer | 7. September 2017 S | 950.312 | 0 | 0 | $0 |
| Pamela Pavco | Chief Development Officer | 1. Februar 2017 A | 17.173 | 0 | 0 | $0 |
| Ronald Todd Plott | Direktor | 29. September 2026 P | 42.000 | 3 | 0 | $27.450 |
| Patricia A Bradford | Direktor | 24. September 2026 P | 64.151 | 2 | 0 | $18.925 |
| Jonathan E Freeman | Direktor | 5. Februar 2026 A | 32.655 | 0 | 0 | $0 |
| David H Deming | Direktor | 5. Februar 2026 A | 37.800 | 0 | 0 | $0 |
| Curtis Lockshin | Direktor | 5. Februar 2026 A | 35.155 | 0 | 0 | $0 |
| Robert L Ferrara | Direktor | 11. September 2025 A | 38.766 | 0 | 0 | $0 |
| Geert Cauwenbergh | Direktor | 17. Februar 2023 A | 4.235 | 0 | 0 | $0 |
| Paul H. Dorman | Direktor | 15. Februar 2022 A | 20.370 | 0 | 0 | $0 |
| Keith L Brownlie | Direktor | 13. Februar 2019 A | 20.000 | 0 | 0 | $0 |
| Advanced RNA Technologies, LLC | · | 31. Juli 2014 P | 1.221.723 | 0 | 0 | $0 |
| Galena Biopharma, Inc. | · | 2. Mai 2013 S | 32.393.095 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 1 ETF
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 94.262 SH | 19. August 2026 | Täglich |
PHIO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 7 Analysten
KAUF
Median-Ziel
$14.00
+1321,2%
2 28,6%
Starker Kauf
4 57,1%
Kauf
1 14,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
1 Analysten · 2026-09-30Mittelwert-Ziel $14.00 +1321,2%
Tief$14.00
Mittelwert$14.00
Hoch$14.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026